Clinical Trial: Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Malignant Solid Neoplasm
Study Type: INTERVENTIONAL
Official Title: A Phase I Study of Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) in Patients With Advanced Solid Tumors
Brief Summary:
This phase I trial tests the safety, side effects, and best dose of a new drug called nab-paclitaxel/STI-3031 complex (AP160-complex) in treating patients with solid tumors that may have spread from where they first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that have spread from where they first started (primary site) to other distant parts of the body (metastatic).AP160-complex is a combination of the chemotherapy drug nab-paclitaxel, and the immunotherapy drug…
Read more